October 28, 2024
A Delaware bankruptcy judge approved DMK Pharmaceuticals' Chapter 11 liquidation plan on Monday, resolving objections from the U.S. Trustee's Office and the unsecured creditors' committee, and aiming to settle approximately $15 million in claims brought by the U.S. Department of Justice.
August 15, 2024
A Manhattan federal judge hit a defunct unit of bankrupt biotechnology concern DMK Pharmaceuticals Corp. with a $10.2 million fine Thursday, after the subsidiary admitted to criminally faking horse-drug prescriptions in a scheme that generated $4.2 million.
July 09, 2024
A subsidiary of bankrupt DMK Pharmaceuticals Corp. faces a $16.9 million criminal fine after pleading guilty to conspiring in a scheme to ship drugs using false prescriptions, federal prosecutors announced Tuesday, adding that the subsidiary's former vice president of sales was also arrested.